World's largest independent biotech firm to pump $245m into Singapore
Purchase this article for republication
Buy SPH photos
This April 20, 2010, file photo shows an exterior view of Amgen offices in California. Amgen Inc. The world's largest biotechnology company announced on Wednesday its plans to build a new manufacturing plant in Singapore. -- PHOTO: AP
Amgen, the world's largest independent biotechnology firm, is setting up its first Asian manufacturing facility in Singapore, the Economic Development Board announced.
The US-based, Fortune 500 company, headquartered in California is expected to invest about US$200 million to build an innovative new facility at the Tuas Biomedical Park.
EDB's director of Biomedical Sciences Kevin Lai said: "Amgen's decision is a strong testament to Singapore's track record in biologics manufacturing. We are proud that the Singapore facility will be Amgen's first major investment in Asia utilising its state-of-the-art technology which will transform the future of biologics industry and making healthcare more affordable."
